|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ELN 6-K filed Jul 22, 2008. Dublin, Ireland and Madison, NJ –
July 22, 2008 –Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE)
today announced that the companies will hold a webcast at 6:00 p.m. Central
Daylight Time (7:00 p.m. Eastern Daylight Time) on Tuesday, July 29, 2008 with
the investment community to discuss the results of the Phase 2 clinical trial of
bapineuzumab for Alzheimer’s disease.
Company
participants who will discuss the trial results and field questions will
include:
Live
audio of the conference call will be simultaneously broadcast over the Internet
and will be available to investors, members of the news media and the general
public. 1
This
event can be accessed by visiting the companies’ web sites at www.elan.com or
www.wyeth.com and clicking on the “Investor Relations”
icon. Following the live webcast, an archived version of the call and
slides will be available at the same URLs.
About
Elan
Elan
Corporation, plc is a neuroscience-based biotechnology company committed to
making a difference in the lives of patients and their families by dedicating
itself to bringing innovations in science to fill significant unmet medical
needs that continue to exist around the world. Elan shares trade on the New
York, London and Dublin Stock Exchanges. For additional information about the
company, please visit www.elan.com.
About
Wyeth
Wyeth
Pharmaceuticals, a division of Wyeth, has leading products in the areas of
women's health care, infectious disease, gastrointestinal health, central
nervous system, inflammation, transplantation, hemophilia, oncology, vaccines
and nutritional products.
Wyeth is
one of the world's largest research-driven pharmaceutical and health care
products companies. It is a leader in the discovery, development, manufacturing
and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals
and non-prescription medicines that improve the quality of life for people
worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth
Consumer Healthcare and Fort Dodge Animal Health. For additional information
about the company, please visit www.wyeth.com.
#####
2 |